Experimentally induced subclinical mastitis: are lipopolysaccharide and lipoteichoic acid eliciting similar pain responses? by Giovannini, Annalisa et al.
Giovannini et al. Acta Vet Scand  (2017) 59:40 
DOI 10.1186/s13028-017-0306-z
RESEARCH
Experimentally induced subclinical 
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Abstract 
Background: Pain accompanying mastitis has gained attention recently as a relevant welfare compromising aspect 
of disease. Adequate pain recognition and therapy are necessary in the context of a modern and ethically accept-
able dairy care. For research purposes mastitis is often induced by intramammary infusion of immunogenic bacterial 
cell wall components. Lipopolysaccharide (LPS) from Escherichia coli and lipoteichoic acid (LTA) from Staphylococcus 
aureus are commonly administered to this end. While the immune response to specific immunogenic components 
has been well characterized, not much is known about their role on the expression of pain indicators. The aim of this 
study was to trial the effects of an intramammary challenge of LTA or LPS on the degree of pain and discomfort as 
indicated by both physiological and behavioral variables in cows. The hypothesis was that a similar degree of pain can 
be identified in LTA as well as in LPS induced mastitis.
Results: On the challenge day, compared to pre-challenge, total pain index increased for all treatment groups (LPS; 
LTA and control), the LPS group having significantly higher values than the control group (P = 0.01). Similarly, pain 
visual analogue scale (VAS) increased significantly in all cows following treatment on the challenge day. Furthermore, 
compared to baseline, higher VAS were found 3, 4 and 5 h after the challenge in cows of the LPS group  (P3h, 4h < 0.001 
and  P5h = 0.001) and 7 h after the challenge in cows of the LTA group  (P7h = 0.002). In the control group, VAS was 
higher 5 h after the challenge  (P5h = 0.001). On the challenge day, udder edema was higher in the LPS than in the 
control group (P = 0.007). Furthermore, 4 h after the challenge, milk cortisol was significantly higher than at baseline 
in the LPS group (P < 0.001).
Conclusions: When administered at equipotent doses targeting a standard somatic cell count increase, intramam-
mary LPS seems to be accompanied by a higher degree of pain and discomfort than LTA, as suggested by the modifi-
cations of the outcome variables total pain index, VAS, udder edema and milk cortisol.
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Background
Bovine bacterial mastitis has been increasingly recog-
nized as a detrimental disease in dairy herds, leading to 
major economic losses and premature culling [1]. Masti-
tis-related pain and discomfort can severely compromise 
animal welfare and deserve to be specifically addressed 
[2]. In the last decade several indicators have been pro-
posed to recognize and quantify pain in bovine mastitis. 
Physiological parameters such as heart rate, respiratory 
rate and temperature [2], modifications of postural and 
ingestive behaviors [3, 4], expression of active behavior 
like stepping, kicking and limb lifting [5, 6] and alteration 
in nociceptive thresholds [7, 8] have been all applied to 
this end.
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Most of the recent research aiming at characteriz-
ing the physiological, immunological and behavioral 
response to pathogenic invasion of the mammary gland 
has been conducted on experimentally induced mastitis 
[6, 7, 9, 10]. Two major immunogenic cell wall compo-
nents, lipoteichoic acid (LTA) and lipopolysaccharide 
(LPS), deriving from Staphylococcus aureus and Escheri-
chia coli respectively, are commonly infused in the bovine 
mammary gland to elicit experimental disease [10–13]. 
In spontaneous mastitis, S. aureus tend to induce a rather 
chronic subclinical disease, while E. coli is typically iso-
lated in acute clinical cases. Whereas a pathogen-specific 
immune response of the mammary gland in LPS and 
LTA-induced mastitis has been confirmed by several 
studies [10, 13, 14], not much is known about the role of 
these specific immunogenic components on the expres-
sion of clinical pain indicators. Indeed, pain-related 
physiological and behavioral alterations have been widely 
investigated in LPS [3, 4, 7] but not in LTA induced mas-
titis. As S. aureus mammary infections lead to breast pain 
in humans [15], we hypothesized that a similar degree of 
pain can be identified in LTA as well as in LPS induced 
mastitis in lactating dairy cows.
The main aim of this study was to trial the effects of an 
intramammary challenge of LTA or LPS on the degree of 
pain and discomfort as indicated by both physiological 
and behavioral variables in cows.
Methods
The study was approved by the Cantonal Commit-
tee for Animal Experimentation, Fribourg, Switzerland 
(FR16/13) and all experimental procedures followed the 
Swiss law of animal protection.
Animals
Sixteen lactating dairy cows (12 Holstein and 4 Swiss 
Fleckvieh) in mid lactation (mean DIM  =  202  ±  88), 
involved in a larger immunological study [13], were 
enrolled in this experiment. Parities of experimen-
tal cows ranged from 1 to 4 (average parity =  2.6) and 
cows were producing  >15  l of milk/day (mean milk 
yield  =  18.4  ±  3.9  l/day). They were housed in a stan-
chion barn and were kept in single rowed tie-stalls (width 
250  cm, length 200  cm) on rubber mats bedded with 
wood shavings and straw. Hay was available ad libitum, as 
well as water (through individual water bowls); concen-
trate was fed according to individual production levels. 
Cows were machine milked at 0530 and 1600  h. Before 
the trial, animals were allowed to acclimatize to the new 
environment for at least 1 week.
Inclusion criteria for the experiment were: body con-
dition score (BCS) of 2.5–3, healthy based on clinical 
examination, negative glutaraldehyde test, normal hema-
tology and blood chemistry, milk somatic cell count 
(SCC) of each quarter <150 × 103 cells/ml and negative 
milk bacteriology.
Experimental design
The study was designed as a prospective, blinded, con-
trolled experimental trial. Cows were randomly allo-
cated to one of 3 treatment groups: LPS group (n = 6), 
LTA group (n = 6) and control group (C group, n = 4). 
For each animal, the trial started 24  h before the 
intramammary challenge and ended 26 h later. A maxi-
mum of two cows were studied at once. On the day pre-
ceding the challenge (control day), baseline outcome 
parameters were measured over 8 h and intramammary 
infusion, milk and blood sampling were simulated at 
the same time points as during the challenge day. Once 
terminated the 8  h data collection, a catheter (length 
105  mm −Ø 1.9  ×  2.4  mm −13  G, Vygon, Ecouten, 
France) was introduced in the jugular vein and a liver 
biopsy was performed. On the challenge day, immedi-
ately after morning milking and following aseptic prep-
aration of the teat, animals received an intramammary 
infusion containing the assigned treatment through a 
sterile teat cannula (length 100 mm, −Ø 22 mm, Delvo, 
Switzerland; time 0). The treatments consisted of 0.2 µg 
LPS (from E. coli serotype O26:B6, Sigma-Aldrich, St. 
Louis, MO, USA) diluted in 10 ml of 0.9% sterile saline 
for group LPS, 20  µg LTA (from S. aureus, Sigma-
Aldrich, St. Louis, MO, USA) diluted in 10  ml of 0.9% 
sterile saline for group LTA, and 10 ml of sterile saline 
0.9% alone for group C. Dosages of LPS and LTA were 
chosen to induce a similar SCC increase. For each ani-
mal 2 randomly allocated quarters (one front and one 
hind) were infused according to the treatment, while 
the other 2 received an equivalent volume of sterile 
0.9% saline. On the challenge day, outcome parameters 
were collected over 8 h starting from time 0. Once ter-
minated the data collection, a liver and two udder biop-
sies on the hind quarters were performed. All biopsies, 
performed for the purpose of the immunological study 
[13] in all groups, were taken in unsedated but physi-
cally restrained cows after skin desensitization with 
10  ml of lidocaine (Lidocaine 2%, Streuli Pharma AG, 
Switzerland). A last clinical examination and recording 
of outcome parameters was performed 26  h after the 
challenge. At this time point, rescue analgesia (3 mg/kg 
ketoprofen IV; Rifen 10%, Streuli Pharma AG, Switzer-
land) was provided if pain visual analogue scale (VAS) 
score  >3 (for VAS description see below). The investi-
gator performing clinical pain assessment (AEJG) was 
blinded to the treatment.
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Outcome parameters
Physiological parameters
The following physiological parameters were recorded 
at hourly intervals: heart rate, respiratory rate and rec-
tal temperature. Heart rate was continuously monitored 
using a portable heart rate monitoring system (Polar 
RS800CX, Polar Electro Europe BV, Switzerland) inserted 
in a girth positioned around the cow’s chest before the 
trial started. Respiratory rate was evaluated through vis-
ual detection of costoabdominal distension, while rectal 
temperature was measured with a digital thermometer.
Ingestive and postural behavior
Time spent eating, ruminating, and lying were automati-
cally recorded for 8  h during both the control and the 
challenge day using a recently validated monitoring sys-
tem (Rumiwatch, Itin+Hoch GmbH, Switzerland) [16]. 
On cows standing with parallel hind limbs, hock-to-hock 
distance was measured every hour with a centimeter-
scaled rolling tape as the distance between the middle 
points of each calcaneal tuberosity [17].
Pain scoring
For pain assessment, a mastitis-specific multidimensional 
pain scoring system was designed. The scoring system was 
organized in two main categories of symptoms, general 
and local, which were further divided in a total of eight 
sub-categories. Each sub-category was scored using sim-
ple numerical rating scales except for the sub-category 
postural behavior, for which a score of 1 was assigned 
to each of the observed manifestations. At each specific 
time point, assigned scores were summed to obtain the 
total pain index, with a maximum possible value of 42 
(Table 1). Furthermore, pain severity was scored using a 
dynamic-interactive VAS on a 100 mm line (0 meaning no 
pain, 100 mm meaning the worst possible pain) [18].
Udder parameters
Udder edema and reaction to udder palpation were 
scored as part of the total pain index (local subcate-
gory items, Table  1) but were also analyzed as separate 
variables.
Udder temperature was measured using an auto-cali-
brating thermic camera (InfraVet OptiRes D, VarioCAM, 
Infra Tech GmbH, Dresden, Germany). Two lateral 
views of the udder were recorded from a 50  cm dis-
tance and on animals left undisturbed for at least 10 min. 
Median udder surface temperature on predefined area 
was detected with a dedicated software (Exam Profes-
sional 5.8, InfraMedic GmbH, Germany), as previously 
described [19, 20].
A purpose-built digital hand-held pressure algom-
eter with a contact surface of 0.5  cm2 was used to test 
the mechanical nociceptive thresholds (MNT) at the 
front quarters at 2 h intervals. Force was applied in cau-
dal direction at a constant rate of 5 N/s perpendicularly 
to the udder surface, dorsally to the teat basis until an 
avoidance behavioral reaction was observed. Maximal 
peak force applicable was set at 24.6  N. Two measure-
ments per quarter, taken at 60 s intervals, were averaged 
for analysis.
Laboratory analysis
During the challenge day, cortisol concentrations in milk 
and plasma aliquots, collected as described by Wall et al. 
[14] and stored at −20  °C, were measured at 2  h inter-
vals with methods described elsewhere [21]. Somatic cell 
count (SCC) in fresh milk samples was measured hourly 
with a DeLaval cell counter (DCC, DeLaval International 
AB, Tumba, Sweden) according to the manufacturer’s 
protocol.
Statistical analysis
Statistical analysis of outcome parameters (see Addi-
tional file 1) was performed using hierarchical regression 
models built with PROC GLIMMIX within SAS 9.4 (SAS 
Institute, Inc., Cary, NC). Cows’ activities eating, rumi-
nating and laying were expressed as a percentage over 
the total recording time and aggregated at day level. The 
quarter outcome variable “reaction to udder palpation” 
was also aggregated at day level and represented whether 
any of the measurements on that day had a value  ≥1. 
Presence of udder edema was classified as yes or no 
applying a binomial distribution. The decimal logarithm 
of milk and plasma cortisol was taken for the data to fol-
low a normal distribution. Cow level models included the 
covariates day, time, and treatment as fixed effects and 
all their 2- and 3-way interactions evaluated. The corre-
lation structure with the best model fit was selected to 
correct for correlation among repeated measurements 
based on the Akaike Information Criterion. For quarter-
level variables, the same modeling procedure was applied 
but “quarter” (infusion yes or no) was additionally evalu-
ated as a fixed effect in the above-mentioned model. 
Moreover, a random intercept was added to correct for 
clustering of quarters within cows. After Bonferroni cor-
rection, significance was defined at P value  <0.0045 for 
cow level outcome variables and at P < 0.01 for quarter 
level outcome variables to correct for multiple compari-
sons. Model fit of linear regression models was checked 
by evaluating normality and homoscedasticity of residu-
als. Reference categories of significant variables were 
changed to perform a post hoc analysis to determine sig-
nificant differences in 2-way or 3-way interaction terms.
Descriptive analysis of cow demographics and spear-
man rank correlation coefficients between total pain 
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index and VAS and between total pain index and SCC 
were calculated using SigmaPlot 12.0 (Systat Software 
GmbH, Germany).
Results
A total of 16 challenges were performed. One cow of the 
LTA group was excluded from statistical analysis because 
it had not responded to the challenge with the expected 
SCC increase. Thus, variables of 15 cases were evaluated. 
No significant differences were found among the groups 
concerning parity and DIM. Similar increases in SCC in 
infused quarters confirmed the equivalence of the LPS 
and LTA doses (Fig. 1).
All cows except one recovered well from the trial, as 
confirmed by the clinical examination 26 h after the chal-
lenge. A single cow in the LPS group received rescue 
analgesia at this time point.
Physiological parameters
No statistical significant difference was detected among 
groups for the variables heart rate, respiratory rate and 
rectal temperature (Table 2).
Table 1 Multidimensional pain scoring system, including general and local items, divided in 8 sub-categories
Assigned scores are added to obtain the total pain index
FL front left quarter, FR front right quarter, HL hind left quarter, HR hind right quarter
Category Sub-category Manifestation Assigned value
General General subjective assessment No signs of pain 0
1
2
3
Signs of severe pain 4
Postural behavior Low, asymmetric ears 1
Corrugated upper eyelids 1
Open nostrils 1
Restless 1
Apathy 1
Wide hind limbs 1
Other (specify) 1
Interactive behavior Interest 0
1
No interest 2
Response to food Appetite 0
1
No appetite at all 2
Sacrum position Normal 0
Downward with arched back 1
Reaction to back palpation No reaction 0
1
Strong reaction 2
Local Udder edema FL 0-1-2-3-4
FR 0-1-2-3-4
HL 0-1-2-3-4
HR 0-1-2-3-4
0 = no swelling, 4 = very severe swelling
Udder palpation FL 0-1-2
FR 0-1-2
HL 0-1-2
HR 0-1-2
0 = no reaction, 1 = mild reaction (tail flicking, limb lifting), 2 = strong reaction (kick, 
moving away)
Total pain index Summation of scores Max 42
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Ingestive and postural behavior
Independently from the group, all cows spent signifi-
cantly less time lying on the challenge day compared 
to the control day (P  <  0.001). No significant difference 
among groups could be found for time spent eating and 
ruminating, although on the challenge day animals of the 
LPS group tended to eat less than those of the C group 
(P = 0.05) (Table 3). No differences in hock-to-hock dis-
tance were found among groups (Table 2).
Pain scoring
The variable total pain index (Fig. 2a, b) had a significant 
day × time interaction (P = 0.002). On the challenge day 
it increased for all 3 treatment groups, the LPS group 
having higher values than the control group (P =  0.01). 
Within the multidimensional pain scoring system, the 
mostly affected sub-categories were appetite, reaction 
to udder palpation and udder edema score. Results for 
udder variables are presented in the following paragraph.
Visual analogue scale data (Fig. 2c, d) showed a signifi-
cant day × time × treatment interaction (P < 0.001). On 
the challenge day, higher VAS were found 3, 4 and 5  h 
after the challenge compared to t0 in cows of the LPS 
group  (P3h, 4h < 0.001 and  P5h = 0.001) and 7 h after the 
challenge in cows of the LTA group  (P7h = 0.002). In the 
control group, VAS was higher 5  h after the challenge 
 (P5h = 0.001). High correlation between total pain index 
and VAS (r = 0.817; P < 0.001), as well as between total 
pain index and SCC of infused quarters (r  =  0.707; 
P < 0.001) were found (Fig. 3).
Udder parameters
A treatment-independent significant day effect 
(P = 0.008) resulted for reaction to udder palpation, with 
higher presence of at least mild responses on the challenge 
day compared to the control day. Udder edema score had 
a significant day  ×  time interaction (P  <  0.001): it was 
increasingly detected over time during the challenge day 
whereas no such increase was observed on the control 
day. On the challenge day, udder edema was higher in 
the LPS than in the C group (P = 0.007) and tended to be 
higher in the LTA group (P = 0.016) than in the C group. 
Moreover, udder edema tended to be higher in infused 
than in control quarters (P = 0.013). For udder tempera-
ture, no day nor quarter effect was found but, compared 
to t0, significantly higher values were found 2 and 8 h after 
the challenge in the LPS group (P = 0.002 and P = 0.004, 
respectively), and 6 and 8 h after the challenge in the LTA 
group (P = 0.006 and P = 0.001, respectively). No changes 
over time were detected for the C group. No statisti-
cal significant difference was detected among groups for 
mechanical nociceptive thresholds (Table 4).
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Fig. 1 Somatic cell count of infused quarters. Changes in somatic cell count of infused quarters in the LPS (lipopolysaccharide) (white circles), LTA 
(lipoteichoic acid) (grey circles) and control groups (black circles) on the challenge day. Data are expressed as mean ± SEM
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Laboratory analysis
For plasma cortisol, no significant difference among 
groups was found (Fig. 4a) but a significant time × treat-
ment effect (P =  0.003) was identified for milk cortisol. 
In the LPS group, 4  h after the challenge, milk cortisol 
was significantly higher than at t0 (P < 0.001); no quar-
ter effect was detected. In the LTA group, 2  h after the 
challenge, milk cortisol was significantly lower than at t0 
(P < 0.001). No changes over time for milk cortisol were 
observed in the C group (Fig. 4b).
Discussion
Aim of this study was to evaluate and compare the 
effects of an intramammary challenge of LTA or LPS on 
the degree of pain and discomfort as indicated by physi-
ological and behavioral variables in cows. Our findings 
indicate that significant alterations of selected outcome 
variables occurred mostly in LPS treated cows, thus lead-
ing to a rejection of the hypothesis that similar degree of 
pain occurs in both LTA and LPS experimentally induced 
mastitis.
In the present study, the physiological outcome vari-
ables heart rate, respiratory rate and rectal tempera-
ture were evaluated. While these parameters have been 
shown to be good indicators of disease severity in spon-
taneously occurring mastitis [17, 22], they were not sig-
nificantly altered by the LPS and LTA treatments, most 
probably due to the fact that sub-clinical disease levels 
were targeted.
On the challenge day, all cows spent less time lying 
than on the control day. Despite the effort to simulate 
all manipulations foreseen for the challenge day on the 
control day, the presence of more people and equipment 
in the barn might have provoked a higher degree of dis-
turbance to the cows, independently from the treatment 
group. Moreover, as udder and liver biopsies were taken 
at the end of the control day, it cannot be excluded that 
residual discomfort in the affected area might have pre-
vented the cows from lying down [23]. For time spent 
lying contrasting results have been previously reported 
in cows affected by LPS-induced mastitis: while in some 
studies a clear reduction of the time spent lying was 
detected after the intramammary challenge [4, 6], in 
others no differences were found [24]. This discrepancy 
might confirm that direct comparison of experimen-
tal results from studies evaluating endotoxins-induced 
mastitis should be performed with caution, as targeted 
levels of severity, and thus clinical and behavioral conse-
quences, might be different.
Several studies on LPS induced mastitis have reported 
reduced food intake and reduced time spent ruminat-
ing following the intramammary challenge [3, 24]. The 
peak effect seems to occur 3–9 h after the LPS challenge 
[24], indicating that the evaluation time of 8 h used in the 
present study should be adequate to detect challenge-
induced alterations if present. While a trend for reduced 
time spent eating was detected in the LPS group, no dif-
ferences among groups were found for time spent rumi-
nating. Similar results have been previously reported [7] 
and, as hypothesized above, they might be linked to the 
severity degree of the disease. The lack of differences 
among groups for the postural variable hock-to-hock 
distance corroborates this hypothesis. Wider hind limb 
stance is expected to occur in cows affected by masti-
tis due to udder inflammation: increased hock-to-hock 
distance was found in mild to moderate clinical mastitis 
cases [17] in one study while it was unchanged in another 
[5].
For pain evaluation, a condition-specific multidi-
mensional pain scale was designed. The structure of the 
scoring system was similar to the one used previously 
in other species [25] but the included items were meant 
to be specific for bovine mastitis and whenever possible 
evidence-based. The first item was a simple numerical rat-
ing scale allowing the observer to attribute a general sub-
jective pain score. The second item was a list of possible 
expected manifestations, the first three being related to 
facial expression. While facial pain scales have not been 
validated so far for bovines, it is generally accepted that 
modifications of facial expression accompanying pain are 
rather conserved among mammal species [26]. Ears, eye-
lid and nostrils modifications indicating pain have been 
described in mice [27], rats [28] and horses [29] and were 
therefore expected to be potentially modified in cows with 
experimentally induced mastitis. Restlessness [5], apathy 
Table 3 Total time spent lying, eating and  ruminating 
by cows challenged with intramammary LPS (lipopolysac-
charide), LTA (lipoteichoic acid) or saline (control group)
On the control day, the intramammary challenge, milk and blood sampling were 
simulated. Medians and interquartile ranges are reported. Recordings were 
performed over 8 h on both the control and the challenge day
Parameter Control day Challenge day
Lying time (min)
 LPS 88.4 (48.8–118.5) 26.4 (18.2–31.6)
 LTA 73.6 (51.4–92.9) 15.4 (0–41.7)
 Control 110.6 (80.2–130.3) 39.1 (11.8–71.4)
Eating time (min)
 LPS 104.3 (82.2–110.7) 73.4 (58.9–89.9)
 LTA 160 (103–183.3) 124 (68.3–178.9)
 Control 146.2 (92.4–215) 167.9 (131.4–208)
Ruminating time (min)
 LPS 186.7 (83.5–201.1) 148.9 (12–146.9)
 LTA 161.2 (140.5–221) 127 (85.1–146.9)
 Control 142.1 (93.7–174.1) 109.1 (95.2–119.3)
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[22] and wide hind limb stance [17] have been previously 
reported in bovine mastitis. Absence of interactive behav-
ior and response to food were included as general sick-
ness indicators [2], while presence of back arch, reported 
in bovine affected by lameness [30] and metritis [31], 
had been observed to occur in clinical mastitis cases and 
was therefore included in the scoring system. Reactiv-
ity to back palpation was expected to potentially occur in 
painful mastitis as a form of secondary hyperalgesia and 
muscle hypersensitivity due to postural abnormalities. 
Additionally, the local items udder edema and reaction to 
udder palpation were meant to provide disease-specific 
information as previously reported [22]. Total pain index 
increased in all treatment groups during the challenge 
day, with significantly higher values for the LPS group 
compared to the control group. These findings suggest 
two considerations. First, a certain treatment-independ-
ent day-time effect is detected by the scale, probably rep-
resenting additional stress provoked by human presence 
during the challenge day. Second, the total pain index 
indicates higher degree of pain following the LPS chal-
lenge. Similarly, the dynamic-interactive VAS pain scores 
were mostly affected by the LPS treatment, even if val-
ues significantly higher than baseline were found for LTA 
and control groups at single time points. Visual analogue 
scales for pain evaluation are daily used in humans [32] 
and have previously been applied to evaluate pain in 
ruminants [18, 33]. For veterinary use, dynamic-interac-
tive VAS scales are generally preferred, as the responses 
to the dynamic interaction with the animal add important 
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information for a correct pain assessment [34]. They are 
based on subjective assessment of pain following observa-
tion and dynamic interaction with the animal. As interob-
server variability might be high, it is important to have a 
single observer throughout the study period when using 
visual analogue scales. In the present study, total pain 
index and dynamic-interactive VAS were significantly 
correlated and led to similar results.
Local signs of disease have been commonly used to 
evaluate the severity of clinical mastitis [22]. In endotox-
ins-induced mastitis, rapid influx of neutrophils in the 
mammary gland occurs [24] accompanied by local signs 
of inflammation, like edema [7], increased udder temper-
ature [17] and hyperalgesia [35].
In the present study, prevalence of udder edema was 
higher in the LPS than in the control group. While udder 
edema has been reported to occur in both experimentally 
induced and naturally occurring coliform mastitis, it does 
not appear to be a typical sign in staphylococcal masti-
tis [36]. Indeed, LTA has been demonstrated to induce 
a weaker effect on vascular permeability [12] than LPS, 
possibly corroborating our findings.
Udder temperature of cows in the LPS and LTA groups 
was higher at some time points after the simulated chal-
lenge/challenge than at their first early morning measure-
ment. Since no day effect could be detected, the changes 
were likely due to treatment-unrelated factors. Udder 
surface temperature has been shown to vary dependently 
on circadian oscillations, stage of lactation, environmen-
tal temperature and physical activity. In the present study 
the highest values were measured at 2, 6 and 8 h after the 
simulated challenge/challenge. Similar findings were pre-
viously reported for healthy cows, where a rise in udder 
temperature was observed between 0900 and 1100 and 
at late afternoon, with minimal values being recorded 
between 0400 and 0600 [37].
No differences in udder mechanical nociceptive thresh-
olds were detected in the present study. Contrasting 
results on nociceptive thresholds have been previously 
reported for mastitic cows. While nociceptive thresholds 
to hind limb and udder laser stimulations increased dur-
ing E. coli mastitis indicating hypoalgesia [8], thresholds 
to thermal hind limb stimulations were lower in cows 
affected by clinical mastitis compared to healthy con-
trols indicating hyperalgesia [35]. Probably the severity 
of systemic illness accompanying the inflammation of 
the mammary gland strongly affects nociceptive thresh-
olds and the reactivity to local stimulation. In presence of 
severe sickness symptoms like somnolence, lethargy and 
depression, it is more likely to observe an increase rather 
a decrease in sensitivity to pain.
While plasma cortisol was not significantly affected by 
treatment and was within the previously reported range 
for healthy lactating dairy cows [38], milk cortisol was sig-
nificantly higher in the LPS group 4 h after the challenge 
compared to t0. Milk cortisol is considered as a useful 
indicator of response to acute stressors acting up to 2  h 
before sampling in lactating dairy cows [39]. As cortisol 
measured in milk derives from the systemic circulation, 
higher milk cortisol might reflect a higher permeability of 
the blood-milk barrier in LPS treated cows. This hypoth-
esis is supported by the finding of higher levels of lactate 
dehydrogenase in LPS compared to LTA treated cows [14]. 
In a recent study, significant effects of SCC on milk cortisol 
were found for SCC above 400 × 103 cells/ml. This finding 
suggests that hypothalamic–pituitary–adrenal axis acti-
vation following an antigenic stimulation can be detected 
only in case of a severe inflammatory response [40].
The LPS dose of 0.2  µg used in the present study is 
lower than what generally described in literature [7], while 
Fig. 3 Correlation between 2 pain scoring methods, and between 
total pain index and somatic cell count. Spearman rank correla-
tion between dynamic interactive visual analogue scale and total 
pain index (TPI) [a, ρ = 0.817 (P < 0.001)], and between somatic cell 
count (SCC) of infused quarters and TPI [b, ρ = 0.707 (P < 0.001)] in 
intramammary LPS (lipopolysaccharide), LTA (lipoteichoic acid) or 
saline challenged cows
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20  µg LTA has been previously administered to com-
pare LTA and LPS induced immune responses [10]. The 
highest SCC values, reached approximately 6 h after the 
challenge, correspond to a subclinical-to-clinical thresh-
old for mastitis. The doses of LPS and LTA were chosen 
to induce a similar SCC increase as previously reported 
[41]. Although using other indicators of mastitis severity 
degree might have led to different results, SCC is a simple 
quantitative measure used both in clinical and in experi-
mental settings and was considered the most adequate to 
compare the immune response to this challenge. Interest-
ingly, a high correlation between total pain index and SCC 
was found, independently from the treatment groups.
Main limitation of the current study is the small size 
of the treatment groups. As both LPS and LTA experi-
mental models of mastitis are highly standardized and 
repeatable [41], groups of 6 animals, as determined for 
the parallel immunological study, were considered to be 
sufficient for the purpose of this study as well; indeed, 
statistically significant results could be found even after 
applying very restrictive Bonferroni corrections. Further-
more, the presence of a small control group in addition 
to the control day in both LPS and LTA groups, contrib-
uted to differentiate between manipulation-induced and 
treatment-induced changes. Another limitation might 
be represented by the fact that the cows included were of 
different breeds and parities. These factors might poten-
tially affect some of the measured outcome variables, 
like it has been recently described for milk cortisol [40]. 
Finally, milk and plasma cortisol concentrations, as well 
as SCC, were not measured on the control day. Therefore, 
only one pre-challenge baseline value was available for 
these variables.
Conclusions
When administered at equipotent doses targeting a 
standard SCC increase, intramammary LPS seems to 
be accompanied by a higher degree of pain and discom-
fort than LTA, as suggested by the modifications of the 
outcome variables total pain index, dynamic interactive 
VAS, udder edema and milk cortisol.
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